Top Markets
Coin of the day
Skye Bioscience, Inc. Skye Bioscience, Inc.

Skye Bioscience, Inc.

SKYE
Kedudukan dalam Saham #31353
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
Harga Saham
$0.4018
Modal Pasaran
$14.12M
Perubahan (1 hari)
-3.20%
Perubahan (1 tahun)
-88.15%
Negara
US
Perdagangan Skye Bioscience, Inc. (SKYE)

Kategori

Sejarah pecahan saham untuk Skye Bioscience, Inc. (SKYE)
Saham Skye Bioscience, Inc. (simbol: SKYE) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 18, 2026.
Satu saham SKYE yang dibeli sebelum Aug 18, 2026 kini bersamaan dengan 0 saham SKYE.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE